US Patent 7271289 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
Patent 7271289 was granted and assigned to Smithkline Beecham Limited on September, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+40 characters)
Article
Patent abstract
Compounds of formula (I):
Edits on 16 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07271289 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors US Patent 7271289 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
Infobox
Patent Number
0727128900
Patent Number
727128900
Edits on 25 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 6 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072712890
Date of Patent
September 18, 2007
0Patent Application Number
105515010
Date Filed
April 7, 2004
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
072712890
Date of Patent
September 18, 2007
0Patent Application Number
105515010
Date Filed
April 7, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 22 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07271289 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07271289
Date of patent
September 18, 2007
Patent application number
10551501
Date Filed
April 7, 2004
Patent primary examiner
Find more entities like US Patent 7271289 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
